•  
  •  
 

Lynchburg Journal of Medical Science

Lynchburg Journal of Medical Science

Specialty

Family medicine, pediatrics, primary care

Advisor

Dr. Thomas Colletti

Abstract

ABSTRACT The purpose of this article is to examine the association of adverse cardiovascular risks with the use of psychostimulant medication used to treat Attention-deficit/hyperactivity disorder (ADHD) in children and adolescents. Physician Assistants who specialize in primary care, family medicine, pediatrics, psychiatry, neurology, pediatric cardiology, and parents of children diagnosed with ADHD will benefit from this article. A review of the cardiovascular effects and risks with psychostimulant treatment will give providers a better understanding with this drug of choice. A PubMed literature search was performed with search terms ADHD, psychostimulants, cardiovascular and children or adolescents. Eleven pertinent sources were retrieved from 2013 to present and served as the basis for this clinical review. Currently there are no available studies with significant data demonstrating a positive association of psychostimulant-related adverse cardiovascular effects in children with ADHD. Cardiac monitoring should be assured from baseline before initiating medication and regularly throughout exposure. Keywords: Psychostimulants, Cardiovascular, ADHD, Adolescents.

Restricted

Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.

Off-campus users can also use 'Off-campus Download' button above for access.

Share

COinS